Gynecologic Cancer
Conference Coverage
Barriers to clinical trial participation revealed by gynecologic cancer patients
A survey suggests a lack of discussion about clinical trials between doctors and patients with gynecologic cancers.
From the Journals
PARP inhibitors not cost effective for platinum-resistant ovarian cancer
Conference Coverage
Vaginal artesunate quells CIN 2/3 lesions, clears HPV
Self-administered treatment with the antimalarial drug artesunate was safe and effective in a small proof-of-concept study.
Applying research to practice
‘Impressive’ SOLO3 results should influence practice
Dr. Alan P. Lyss reviews data showing that olaparib outperformed chemotherapy in patients with heavily pretreated ovarian cancer.
Guidelines
Guidelines on delaying cancer surgery during COVID-19
The American College of Surgeons has issued new guidelines for cancer surgery in the era of COVID-19.
Commentary
Perspective from the heartland: Cancer care and research during a public health crisis
Dr. Alan P. Lyss examines how the COVID-19 pandemic has and will affect cancer care and research.
Perspectives
How long is it safe to delay gynecologic cancer surgery?
Surgical triage is necessary when resources are scarce.
Latest News
Cancer care and COVID-19 in Seattle, the first U.S. epicenter
Feature
How is oncology adapting to COVID-19?
Feature
Disruptions in cancer care in the era of COVID-19
From the Journals
HPV vaccine-chemo combo prolongs cervical cancer survival
Longer survival was observed in women with a stronger immune response to human papillomavirus vaccination during chemotherapy.